Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kim & Chang is Korea’s largest and most prominent law firm. Founded in 1973, it provides comprehensive legal services across all major practice areas—including a leading life sciences and healthcare regulatory team that advises multinational pharmaceutical, biotech, medical device, diagnostics companies on Korean market access, compliance with local regulations (e.g., Pharmaceutical Affairs Law), pricing/reimbursement strategies under the National Health Insurance Act, product recalls/adverse event reporting requirements, digital health regulations (AI/wearables/genomics), IP protection for drugs/devices/diagnostics—and represents clients in government investigations or enforcement actions[5][6]. However, it does not develop drugs or have its own clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kim & Chang.